jiesheng Tian

Dr. jiesheng Tian


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Biomaterials
Verified
Journal Article
Closed access
ZXZhichu Xiang
Zhichu Xiang
XYXiaoliang Yang
Xiaoliang Yang
JXJunjie Xu
Junjie Xu
WLWenjia Lai
Wenjia Lai
Zihua WangZihua Wang
Zihua Wang
QFQiaojun Fang
Qiaojun Fang

1 September 2010 in International Journal of Systematic and Evolutionary Microbiology
Verified
Journal Article
Closed access
MXMingshuang Xu
Mingshuang Xu
YXYuhua Xin
Yuhua Xin
YYYong Yu
Yong Yu
JZJianli Zhang
Jianli Zhang
YZYuguang Zhou
Yuguang Zhou
YLYing Li
Ying Li
A novel Gram-negative, orange-pigmented, slightly halophilic, rod-shaped bacterium, strain T30T, was isolated from sediment from the South China Sea. Phylogenetic analysis showed that strain T30Twas a member of the genusErythrobacter, sharing highest 16S rRNA gene sequence similarities withErythrobacteraquimarisJCM 12189T(99.5 %) andErythrobactervulgarisDSM 17792T(99.0 %). Levels of DNA–DNA relatedness between strain T30Tand closely related strains ofErythrobacterspecies ranged from 14.5 to 56.9 %.The isolate lacked bacteriochlorophyllaand contained ubiquinone-10 as the predominant respiratory lipoquinone. The major fatty acids of this strain were C18 : 1ω7c(38.2 %) and C16 : 1ω7c/C16 : 1ω6c(17.4 %). The major polar lipids were phosphatidylethanolamine, diphosphatidylglycerol, phosphatidylcholine and phosphatidylglycerol. The DNA G+C content of strain T30Twas 59.5 mol%. On the basis of phenotypic and phylogenetic data, a novel species,Erythrobacter nanhaisediminissp. nov., is proposed; the type strain is T30T(=CGMCC 1.7715T=JCM 16125T).

30 September 2010 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
ALAihua Li
Aihua Li
HZHuiyuan Zhang
Huiyuan Zhang
XZXin Zhang
Xin Zhang
QWQi Wang
Qi Wang
JTjiesheng Tian
jiesheng Tian
JLJilun Li
Jilun Li

6 March 2019 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
JXJunjie Xu
Junjie Xu
LLLingzi Liu
Lingzi Liu
JHJinxin He
Jinxin He
SMShijiao Ma
Shijiao Ma
SLShuli Li
Shuli Li
FLFeng Li
Feng Li
Magnetosomes (also called bacterial magnetic nanoparticles; BMPs) are biomembrane-coated nanoparticles synthesized by magnetotactic bacteria (MTB). Engineered BMPs fused to protein A (termed ∆F-BMP-FA) bind antibodies (Abs) automatically, and thus provide a series of potential advantages. However, no report so far has systematically evaluated functional applicability of genetically engineered BMPs. We evaluated properties of ∆F-BMP-FA, and developed/optimized culture methods for host strain Magnetospirillum gryphiswaldense ΔF-FA, ∆F-BMP-FA extraction conditions, conditions for Ab conjugation to ∆F-BMP-FA surface, and procedures for antigen detection using ∆F-BMP-FA/Ab complexes (termed BMP-A-Ab). Fed-batch culture for 36 h in a 42-L fermentor resulted in yields (dry weight) of 2.26 g/L for strain ΔF-FA and 62 mg/L for ∆F-BMP-FA. Optimal wash cycle number for ∆F-BMP-FA purification was seven, with magnetic separation following each ultrasonication step. Fusion of protein A to BMPs resulted in ordered arrangement of Abs on BMP surface. Linkage rate 962 μg Ab per mg ∆F-BMP-FA was achieved. BMP-A-Ab were tested for detection of pathogen (Vibrio parahaemolyticus; Vp) surface antigen and hapten (gentamicin sulfate). Maximal Vp capture rate for BMP-A-Ab was 90% (higher than rate for commercial immunomagnetic beads), and detection sensitivity was 5 CFU/mL. ∆F-BMP-FA also bound Abs from crude mouse ascites to form complex. Lowest gentamicin sulfate detection line for BMP-A-Ab was 0.01 ng/mL, 400-fold lower than that for double Ab sandwich ELISA, and gentamicin sulfate recovery rate for BMP-A-Ab was 93.2%. Our findings indicate that engineered BMPs such as ∆F-BMP-FA are inexpensive, eco-friendly alternatives to commercial immunomagnetic beads for detection or diagnostic immunoassays, and have high Ab-conjugation and antigen-adsorption capacity.

7 May 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
XNXiaohui Nan
Xiaohui Nan
WLWenjia Lai
Wenjia Lai
DLDan Li
Dan Li
JTjiesheng Tian
jiesheng Tian
Zhiyuan HuZhiyuan Hu
Zhiyuan Hu
QFQiaojun Fang
Qiaojun Fang
Derived from magnetotactic bacteria (MTB), magnetosomes consist of magnetite crystals enclosed within a lipid bilayer membrane and are known to possess advantages over artificially synthesized nanoparticles because of the narrow size distribution, uniform morphology, high purity and crystallinity, single magnetic domain, good biocompatibility, and easy surface modification. These unique properties have increasingly attracted researchers to apply bacterial magnetosomes (BMs) in the fields of biology and medicine as MRI imaging contrast agents. Due to the concern of biosafety, a long-term follow-up of the distribution and clearance of BMs after entering the body is necessary. In this study, we tracked changes of BMs in major organs of mice up to 135 days after intravenous injection using a combination of several techniques. We not only confirmed the liver as the well-known targeted organs of BMs, but also found that BMs accumulated in the spleen. Besides, two major elimination paths, as well as the approximate length of time for BMs to be cleared from the mice, were revealed. Together, the results not only confirm that BMs have high biocompatibility, but also provide a long-term in-vivo assessment which may further help to forward the clinical applications of BMs as an MRI contrast agent.

1 February 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SMShijiao Ma
Shijiao Ma
CGChenchen Gu
Chenchen Gu
JXJunjie Xu
Junjie Xu
JHJinxin He
Jinxin He
SLShuli Li
Shuli Li
JTjiesheng Tian
jiesheng Tian
Purpose: Nanoparticles (NPs) decorated with functional ligands are promising candidates for cancer diagnosis and treatment. However, numerous studies have shown that chemically coupled targeting moieties on NPs lose their targeting capability in the biological milieu because they are shielded or covered by a “protein corona”. Herein, we construct a functional magnetosome that recognizes and targets cancer cells even in the presence of protein corona. Methods: Magnetosomes (BMPs) were extracted from magnetotactic bacteria, M. gryphiswaldense (MSR-1), and decorated with trastuzumab (TZ) via affibody (RA) and glutaraldehyde (GA). The engineered BMPs are referred to as BMP-RA-TZ and BMP-GA-TZ. Their capacities to combine HER2 were detected by ELISA, the quantity of plasma corona proteins was analyzed using LC-MS. The efficiencies of targeting SK-BR-3 were demonstrated by confocal laser scanning microscopy and flow cytometry. Results: Both engineered BMPs contain up to ∼ 0.2 mg TZ per mg of BMP, while the quantity of HER2 binding to BMP-RA-TZ is three times higher than that binding to BMP-GA-TZ. After incubation with normal human plasma or IgG-supplemented plasma, GA-TZ-containing BMPs have larger hydrated radii and more surface proteins in comparison with RA-TZ-containing BMPs. The TZ-containing BMPs all can be targeted to and internalized in the HER2-overexpressing breast cancer cell line SK-BR-3; however, their targeting efficiencies vary considerably: 50– 75% for RA-TZ-containing BMPs and 9– 19% for GA-TZ-containing BMPs. BMPs were incubated with plasma (100%) and cancer cells to simulate human in vivo environment. In this milieu, BMP-RA-TZ uptake efficiency of SK-BR-3 reaches nearly 80% (slightly lower than for direct interaction with BMP-RA-TZ), whereas the BMP-GA-TZ uptake efficiency is < 17%. Conclusion: Application of the RA scaffold promotes and orients the arrangement of targeting ligands and reduces the shielding effect of corona proteins. This strategy improves the targeting capability and drug delivery of NP in a simulated in vivo milieu.